{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:10:02Z","timestamp":1759093802168,"version":"3.44.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ijcard.2019.03.027","type":"journal-article","created":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T02:28:07Z","timestamp":1552789687000},"page":"132-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pulmonary hypertension in left heart disease: The need to continue to explore"],"prefix":"10.1016","volume":"288","author":[{"given":"Stefano","family":"Ghio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"D'Alto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Badagliacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine Dario","family":"Vizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.03.027_bb0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0010","article-title":"Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: a meta-analysis","author":"Cao","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","article-title":"Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure","volume":"37","author":"Ghio","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2018.12.078","article-title":"Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension","author":"Kramer","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0025","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejheart.2004.10.021","article-title":"Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure","volume":"7","author":"Delgado","year":"2005","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1164\/rccm.201206-1049ED","article-title":"Progress in pulmonary arterial hypertension pathology: relighting a torch inside the tunnel","volume":"186","author":"Dorfmuller","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.ijcard.2019.03.027_bb0035","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01897-2018","article-title":"Pulmonary hypertension due to left heart disease","volume":"53","author":"Vachi\u00e9ry","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0040","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1378\/chest.12-1653","article-title":"Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in \u201cout-of-proportion\u201d pulmonary hypertension","volume":"143","author":"Gerges","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2019.03.027_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.healun.2013.11.008","article-title":"Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension","volume":"33","author":"Tedford","year":"2014","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0050","first-page":"9","article-title":"The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease","volume":"3","author":"Tampakakis","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0735-1097(93)90812-F","article-title":"Twenty-fourth Bethesda Conference: cardiac transplantation. Task Force 3: recipient guidelines\/prioritization","volume":"22","author":"Mudge","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0060","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2006.06.008","article-title":"Listing criteria for heart trans- plantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates \u2013 2006","volume":"25","author":"Mehra","year":"2006","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0065","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.athoracsur.2007.01.019","article-title":"Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices","volume":"83","author":"Etz","year":"2007","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.healun.2009.05.030","article-title":"Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support","volume":"29","author":"Torre-Amione","year":"2010","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MAT.0000000000000467","article-title":"Pulmonary arterial compliance improves rapidly after left ventricular assist device implantation","volume":"63","author":"Masri","year":"2017","journal-title":"ASAIO J."},{"issue":"11","key":"10.1016\/j.ijcard.2019.03.027_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188383","article-title":"Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension","volume":"12","author":"Ghio","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2019.03.027_bb0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ejhf.1067","article-title":"Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension","volume":"20","author":"Ghio","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0090","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ejhf.664","article-title":"Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction","volume":"19","author":"Ghio","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ahj.2017.06.006","article-title":"Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: similarities and disparities","volume":"192","author":"Adir","year":"2017","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0105","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/01.CIR.102.14.1718","article-title":"Secondary pulmonary hypertension in chronic heart failure. The role of the endothelium in pathophysiology and management","volume":"102","author":"Moraes","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.03.027_bb0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","article-title":"A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0115","unstructured":"Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF). ClinicalTrials.gov Identifier: NCT03037580."},{"issue":"5","key":"10.1016\/j.ijcard.2019.03.027_bb0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hlc.2016.09.004","article-title":"Pilot study of endothelin receptor blockade in heart failure with diastolic dysfunction and pulmonary hypertension (BADDHY-trial)","volume":"26","author":"Koller","year":"2017","journal-title":"Heart Lung Circ."},{"issue":"2","key":"10.1016\/j.ijcard.2019.03.027_bb0125","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01886-2017","article-title":"Macitentan in pulmonary hypertension due to left ventricular dysfunction","volume":"51","author":"Vachi\u00e9ry","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.113.001458","article-title":"Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo- controlled, dose-ranging hemodynamic study","volume":"128","author":"Bonderman","year":"2013","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ijcard.2019.03.027_bb0135","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.107.716373","article-title":"Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension","volume":"116","author":"Lewis","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0140","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.110.983866","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study","volume":"124","author":"Guazzi","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.03.027_bb0145","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/eurheartj\/ehv336","article-title":"Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial","volume":"36","author":"Hoendermis","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0150","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/eurheartj\/ehx700","article-title":"Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial","volume":"39","author":"Bermejo","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.03.027_bb0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","article-title":"Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial","volume":"387","author":"Abraham","year":"2016","journal-title":"Lancet"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319305716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319305716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:41:34Z","timestamp":1759092094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319305716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":31,"alternative-id":["S0167527319305716"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.03.027","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary hypertension in left heart disease: The need to continue to explore","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.12.078","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}